Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharma. Regulatory News (CEL)

Share Price Information for Celadon Pharma. (CEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.50
Bid: 85.00
Ask: 86.00
Change: -9.00 (-9.47%)
Spread: 1.00 (1.176%)
Open: 95.00
High: 95.00
Low: 86.00
Prev. Close: 95.00
CEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.1- (Celsis International)

14 Aug 2009 10:07

RNS Number : 4562X
North Atlantic Value LLP
14 August 2009
 



FORM 8.1

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the Takeover Code)

1. KEY INFORMATION

Name of person dealing (Note 1)

Nastor Investments Limited, North Atlantic Value LLP

Company dealt in

Celsis International Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary 5p shares

Date of dealing

13 August 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

4,425,893 (20.2%)

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

4,425,893 (20.2%)

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

(c) Rights to subscribe (Note 3)

Class of relevant security:

Details

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unit (Note 5)

Purchase

25,000

£2.325

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5) 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

14 August 2009

Contact name

Mark Purnell

Telephone number

020 7747 5678

Name of offeree/offeror with which associated

Nastor Investments Limited, North Atlantic Value LLP

Specify category and nature of associate status (Note 10)

Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCCKQKKCBKKPFD
Date   Source Headline
23rd May 20247:00 amRNSSupply of Products to New US Customer
15th May 20242:45 pmRNSExercise of Share Options and Total Voting Rights
14th May 20247:00 amRNSFinal Results
10th May 20247:00 amRNSFundraise, RCF Extension, Termination of CLN & TVR
7th Mar 20247:00 amRNSEarly Economic Analysis of Feasibility Study Data
14th Dec 20237:00 amRNSProduct Supplied to First Two Sales Contracts
12th Dec 20232:00 pmRNSFundraise, Update on Future CLN Financing & TVR
16th Nov 20237:00 amRNSNew European Sales Contract
13th Oct 20237:00 amRNSFundraise, CLN Issue, Joint Broker Appointed & TVR
28th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSNotice of Results and Investor Presentation
5th Sep 20237:00 amRNSNew Sales Contract with UK Pharmaceutical Company
1st Aug 20237:00 amRNSApproval to roll-out chronic pain clinical trial
29th Jun 20235:30 pmRNSResult of AGM
5th Jun 20232:46 pmRNSPublication of Annual Report and Notice of AGM
5th Jun 20237:00 amRNSFinal Results for the year ended 31 December 2022
30th May 20237:00 amRNS£7 Million Committed Credit Facility
26th May 20237:00 amRNSNotice of Results and Investor Presentation
25th May 20237:00 amRNSWest Midlands Mayor Visits Celadon’s Facility
24th May 20237:00 amRNSInaugural Supply Contract Win
29th Mar 202311:05 amRNSSecond Price Monitoring Extn
29th Mar 202311:00 amRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20232:05 pmRNSSecond Price Monitoring Extn
17th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20233:01 pmRNSSuccessful Update to Home Office Licence
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 20234:40 pmRNSSecond Price Monitoring Extn
10th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20232:15 pmRNSNotification of transaction by PDMR
19th Jan 20237:00 amRNSChange of Website Address
16th Jan 20237:00 amRNSApproval of GMP Registration by MHRA
13th Jan 20237:00 amRNSUpdate on CFO Appointment
30th Dec 20227:00 amRNSResults of Feasibility Study
22nd Dec 20227:00 amRNSUpdate on GMP Registration by MHRA
1st Nov 20227:00 amRNSAppointment of CFO
29th Sep 20227:00 amRNSInterim Report for six months ended 30 June 2022
12th Sep 20227:00 amRNSNotice of Results
28th Jul 20227:00 amRNSAppointment of Tessera Investment Management
27th Jun 20226:15 pmRNSResult of AGM
22nd Jun 20227:00 amRNSBusiness Update
31st May 20221:30 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFull year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.